Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
Farmers Insurance
Federal Trade Commission
UBS
Deloitte

Generated: April 26, 2019

DrugPatentWatch Database Preview

Famciclovir - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for famciclovir and what is the scope of famciclovir freedom to operate?

Famciclovir is the generic ingredient in two branded drugs marketed by Apotex, Aurobindo Pharma Ltd, Cipla, Hetero Labs Ltd V, Macleods Pharms Ltd, Mylan, Teva Pharms, West-ward Pharms Int, and Novartis, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for famciclovir. Sixteen suppliers are listed for this compound.

Pharmacology for famciclovir
Synonyms for famciclovir
[2-(acetoxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate
[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)-butyl] acetate
[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate
1,3-diyl diacetate
1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester)
1,3-Propanediol, 2-[2-(2-amino-9H-purin-9-yl)ethyl]-, 1,3-diacetate
1,3-propanediol, 2-[2-(2-amino-9H-purin-9-yl)ethyl]-, diacetate (ester)
104227-87-4
2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate
2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester)
2-(2-(2-AMINO-9H-PURIN-9-YL)ETHYL)-1,3-PROPANEDIOL DIACETATE ESTER
2-(2-(2-amino-9H-purin-9-yl)ethyl)propane-
2-(2-(2-Amino-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate
2-(acetoxymethyl)-4-(2-amino-4,5-dihydro-9H-purin-9-yl)butyl acetate
2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate
2-[2-(2-amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate
2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate (ester)
2-[2-(2-Amino-9H-purin-9-yl)ethyl]trimethylene diacetate;2-[2-(2-Amino-9H-purin-9-yl)ethyl]trimethylene diacetate
227F874
9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine
9-(4-acetoxy-3-acetoxymethylbut-1-yl)-2-aminopurine
9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
9-[4-acetoxy-3-(acetoxymethyl)butyl]-2-amino-9h purine
A19583
AB0013893
AB00639952_09
AB00639952_10
AB00639952-06
AB00639952-08
AB07547
AB2000579
AC-8066
AC1L1FOB
Acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester
AJ-26674
AK-120
AKOS005556609
ALBB-027262
AN-8356
Anti-Farnesyl Rabbit pAb
ANW-58321
BC201648
BCP21312
BRD-K45033733-001-02-3
BRD-K45033733-001-05-6
BRL 42810
BRL-42810
BSPBio_003489
C14H19N5O4
CAS-104227-87-4
CCG-39277
CF0039
CHEBI:4974
CHEMBL880
CJ-23991
CPD000466375
CS-1357
CTK8B7737
D00317
DB00426
Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine
DSSTox_CID_3038
DSSTox_GSID_23038
DSSTox_RID_76845
DTXSID0023038
F0842
Famciclovir (Famvir)
Famciclovir (JAN/USAN/INN)
Famciclovir [USAN:BAN:INN]
Famciclovir [USAN:INN:BAN]
Famciclovir, >=98% (HPLC)
Famciclovir, Pharmaceutical Secondary Standard; Certified Reference Material
Famciclovir, United States Pharmacopeia (USP) Reference Standard
Famciclovir,(S)
Famciclovirum
Famciclovirum [INN-Latin]
Famvir
Famvir (TN)
FCV
FT-0602549
GGXKWVWZWMLJEH-UHFFFAOYSA-N
HMS1922L09
HMS2051G22
HMS2090G10
HMS2093K12
HMS2232H09
HMS3262O08
HMS3370D14
HMS3393G22
HMS3656A04
HMS3715F03
HSDB 8121
HY-17426
I03-0096
I789
IN1338
J-001134
K-0411
KB-220353
KBio2_000946
KBio2_003514
KBio2_006082
KBio3_002709
KBioGR_001162
KBioSS_000946
KS-00000XOD
KS-5020
LS-120147
MCULE-6850246103
MFCD00866964
MLS000759505
MLS001424115
MLS006011896
MolPort-003-666-602
NC00156
NCGC00095133-01
NCGC00095133-02
NCGC00095133-03
NCGC00095133-04
NCGC00095133-06
NCGC00261478-01
NSC-758921
NSC758921
Oravir
Pharmakon1600-01505201
QIC03ANI02
RT-012693
s2467
SAM001246732
SBI-0206743.P001
SC-43883
SCHEMBL2949
SMR000466375
SPBio_001202
Spectrum_000466
SPECTRUM1505201
Spectrum2_001101
Spectrum3_001675
Spectrum4_000611
Spectrum5_001548
SR-01000759358
SR-01000759358-4
SR-01000759358-5
STK623204
SW197536-3
Tox21_111442
Tox21_111442_1
Tox21_500793
UNII-QIC03ANI02
ZINC1530635

US Patents and Regulatory Information for famciclovir

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int FAMCICLOVIR famciclovir TABLET;ORAL 090128-001 Mar 21, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan FAMCICLOVIR famciclovir TABLET;ORAL 201333-003 Mar 24, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Macleods Pharms Ltd FAMCICLOVIR famciclovir TABLET;ORAL 201022-001 Jan 12, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for famciclovir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis FAMVIR famciclovir TABLET;ORAL 020363-001 Apr 26, 1996 ➤ Sign Up ➤ Sign Up
Novartis FAMVIR famciclovir TABLET;ORAL 020363-001 Apr 26, 1996 ➤ Sign Up ➤ Sign Up
Novartis FAMVIR famciclovir TABLET;ORAL 020363-003 Dec 11, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Citi
QuintilesIMS
Moodys
Argus Health
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.